Avadel Pharmaceuticals (AVDL) Return on Sales (2016 - 2021)
Historic Return on Sales for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q1 2021 value amounting to 0.08%.
- Avadel Pharmaceuticals' Return on Sales rose 9300.0% to 0.08% in Q1 2021 from the same period last year, while for Mar 2021 it was 0.08%, marking a year-over-year increase of 14100.0%. This contributed to the annual value of 0.28% for FY2020, which is 10000.0% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported Return on Sales of 0.08% as of Q1 2021, which was up 9300.0% from 0.29% recorded in Q4 2020.
- In the past 5 years, Avadel Pharmaceuticals' Return on Sales registered a high of 3.06% during Q2 2020, and its lowest value of 4.14% during Q4 2019.
- In the last 5 years, Avadel Pharmaceuticals' Return on Sales had a median value of 0.37% in 2018 and averaged 0.44%.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Return on Sales tumbled by -28200bps in 2018, and later skyrocketed by 44300bps in 2020.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Return on Sales stood at 0.24% in 2017, then crashed by -1187bps to 3.05% in 2018, then plummeted by -36bps to 4.14% in 2019, then skyrocketed by 107bps to 0.29% in 2020, then plummeted by -73bps to 0.08% in 2021.
- Its last three reported values are 0.08% in Q1 2021, 0.29% for Q4 2020, and 1.1% during Q3 2020.